XML 93 R78.htm IDEA: XBRL DOCUMENT v3.24.2
Liabilities Related to Business Combinations and to Non-Controlling Interests - Additional Information (Details) - EUR (€)
€ in Millions
Jun. 30, 2024
Dec. 31, 2023
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Line Items]    
Fair value of contingent consideration payable [1] € 728 € 709
MSD contingent consideration (European Vaccines business)    
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Line Items]    
Fair value of contingent consideration payable € 61 127
Increase in fair value of liability 1.00%  
Shire contingent consideration arising from acquisition of Translate Bio    
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Line Items]    
Fair value of contingent consideration payable € 526 441
Increase in fair value of liability 14.00%  
Contingent consideration arising from acquisition of Amunix    
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Line Items]    
Fair value of contingent consideration payable € 140 € 137
[1] As of January 1, 2024, this comprised a non-current portion of €501 million and a current portion of €208 million.